openPR Logo
Press release

Pharmacy OneSource Announces Free Webinar on Multi-drug Resistant Organism

07-25-2011 08:35 AM CET | Health & Medicine

Press release from: Pharmacy OneSource

Interventions to Prevent Acinetobacter baumannii in Healthcare Settings

Bellevue, Wash. – Wolters Kluwer Health announced today that Pharmacy OneSource, software-as-a-service provider of Sentri7, an infection prevention surveillance, documentation and reporting application, is hosting a complimentary webinar with Jackie Whitaker, RN, MS, LHCRM, CIC, on "MDR Acinetobacter baumannii in the Short Term and Long Term Acute Care Setting."

Multi-drug resistant Acinetobacter baumannii is a health care-associated pathogen that can live for months in both a wet and dry environment. The high prevalence of this organism in the hospital environment results in colonization of the skin and respiratory tract. Mortality due to MDR Acinetobacter baumaunnii can run as high as 80%. Whitaker will review a study of interventions used to reduce the incidence of Acinetobacter baumannii infection and colonization. Interventions included 10% hypochlorite disinfection, hand hygiene, special contact isolation for suspected and confirmed cases, an educational tool for clinicians, patient and visitors, daily isolation rounds, automated report functions, and standardized nursing unit isolation practices.

MDR Acinetobacter baumannii in the Short Term and Long Term Acute Care Setting
DATE: August 3, 2011
TIME: 12:00 PM - 1:00 PM EST
WHERE: http://www.sentri7.com/infection

About the Presenter: Jackie Whitaker, RN, MS, LHCRM, CIC, has been an infection prevention and control specialist in the acute care setting for 20 years. An APIC member for 18 years, Jackie has also held a license in health care risk management since 2002. Actively involved in her local chapter Jackie has served as President, Secretary and been a member of the Nominating Committee.

Whitaker has extensive experience in project management and program design for a multitude of health care services, including, infection control, employee health, occupational health, infusion services, National Patient Safety Goals programs, etc. Through the utilization of technology and performance improvement tools, Whitaker and her team have effected excellent patient outcomes. She received 5 VHA awards for infection prevention projects to improve patient outcomes. Her interest in serving on the APIC Board of Directors is a result of her wanting to better serve her peers and the public in a broader capacity in infection prevention initiatives.

About Pharmacy OneSource
Pharmacy OneSource® is healthcare's #1 Software-as-a-Service (SaaS) provider. Our more than 100 innovative team members provide best-in-class, SaaS solutions to current and future challenges within health-systems worldwide. Our SaaS solutions contribute to swift and safe healthcare through earlier, easier and better access to data. More than 1,300 healthcare organizations worldwide utilize our HIPAA compliant web-based services.

Pharmacy OneSource is part of Wolters Kluwer Health, a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company with 2010 annual revenues of €3.6 billion ($4.7 billion).

Pharmacy OneSource
3535 Factoria Blvd. SE #440
Bellevue, WA 98006

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmacy OneSource Announces Free Webinar on Multi-drug Resistant Organism here

News-ID: 184636 • Views:

More Releases from Pharmacy OneSource

Richie's Specialty Pharmacy Selects Simplifi 797 for USP 797 Compliance
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Richie's Specialty Pharmacy, LLC has selected its Simplifi 797 software for achieving sterile compounding compliance. Simplifi 797 is a web-based application that automates, integrates and streamlines quality activities and documentation related to U.S. Pharmacopeia's Chapter 797 guidelines. The software manages task scheduling for environmental monitoring and automates the reporting of exceptions and compliance. "Simplifi
Pharmacy OneSource® Partners with CriticalPoint™ to Offer the Next Generation …
Bellevue, Washington – Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Pharmacy OneSource® has released a new version of Simplifi 797®, a web-based quality assurance software for USP chapter 797 compounding compliance. The upgraded version of Simplifi 797 includes CriticalPoint's education program, which gives users unlimited access to 42 hours of ACPE-approved continuing education credits supporting compliance with USP Chapter . Lessons
Wolters Kluwer Health Unveils Integration between UpToDate and Sentri7
Bellevue, WA -- Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that UpToDate's clinical knowledge system has been integrated with Sentri7 surveillance software by Pharmacy OneSource. This partnership of evidence-based clinical information through UpToDate and clinical patient surveillance from Sentri7 offers healthcare providers actionable information at the point of care to make better decisions in directing patient care. UpToDate synthesizes the most recent medical

More Releases for Acinetobacter

Global Acinetobacter Infections Treatment Market Manufacturers, Type, Applicatio …
A recent report published by QY Research, titled, Acinetobacter Infections Treatment, provides an in-depth analysis of the global Acinetobacter Infections Treatment market. The research report is divided in a way to highlight the key areas of the market and provide a comprehensive understanding to the reader. The report deals with various aspects of the Acinetobacter Infections Treatment market such as its scope to studies its drivers and the restrains, market
Global Acinetobacter Infections Treatment Market Research Report 2020
LOS ANGELES - USA, Acinetobacter is a group of bacteria commonly found in soil and water. While there are many types or "species" of Acinetobacter and all can cause human disease, Acinetobacter baumannii accounts for about 80% of reported infections. Outbreaks of Acinetobacter infections typically occur in intensive care units and healthcare settings housing very ill patients. Acinetobacter infections rarely occur outside of healthcare settings. Acinetobacter is often resistant to many commonly
United States Acinetobacter Infections Treatment Market Overview And Forecasts 2 …
Qyresearchreports include new market research report "United States Acinetobacter Infections Treatment Market Report 2018" to its huge collection of research reports. The United States Acinetobacter Infections Treatment market has been meticulously researched on and studied and detailed on in this publication with the help of advanced primary and secondary research that has been performed by the best of analysts and using the best of the available techniques. The publications that enable
Acinetobacter Infections Treatment Market Share and Forecasts Research Report 20 …
Acinetobacter Infections Treatment market get comprehensive research offering detailed regional analysis and growth outlook in a new report now available at MarketStudyReport.com An inherent sub-vertical of the Healthcare industry space, Acinetobacter Infections Treatment Market stands to gain remarkable proceeds over 2018-2023, as per a recently compiled report. Covering the pivotal geographies of the Asia Pacific, Middle East and Africa (MEA), South America, North America, and Europe, this report minutely categorizes global
Acinetobacter Infections Treatment Market with Worldwide Industry Analysis to 20 …
Global Acinetobacter Infections Treatment Market: Overview Acinetobacter baumannii is a rod shaped gram-negative coccobacillus bacterium. This bacterium is becoming an important cause of hospital derived bacterial infection affecting people with weakened immune system. Acinetobacter infections usually affect organ systems, which have a high content of fluid (e.g. peritoneal fluid, respiratory tract, urinary tract, cerebrospinal fluid etc.) leading to infections related to continuous ambulatory peritoneal dialysis and nocosomial pneumonia. At present,
Acinetobacter Infections - Pipeline Review, H1 2017 - Pharmaceutical Market Repo …
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acinetobacter Infections - Pipeline Review, H1 2017, provides an overview of the Acinetobacter Infections (Infectious Disease) pipeline landscape. Acinetobacter is a gram-negative coccobacillus. Acinetobacter infections are uncommon but, when they occur, usually involve organ systems that have a high fluid content (respiratory tract, CSF, peritoneal fluid, urinary tract). Symptoms include fever (high body temperature), red, swollen, warm or painful skin areas